title: Multiple sclerosis: Is there a safe time to discontinue therapy in MS?
authors.affiliation: Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada.
authors.forename: Mark S
authors.initials: MS
authors.lastname: Freedman
mesh_terms: D000328:Adult; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D055118:Medication Adherence; D008875:Middle Aged; D020528:Multiple Sclerosis, Chronic Progressive / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D007155:Immunologic Factors